Home » Patient Taking Novartis MS Pill Developed Rare Disease
Patient Taking Novartis MS Pill Developed Rare Disease
A patient that had been on Novartis’ Gilenya pill for multiple sclerosis developed progressive multifocal leukoencephalopathy.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May